Key result
Cardiac valve replacement with the Delrin-disc Björk-Shiley prosthesis yielded an actuarial survival of 84.8% at 5 years and 78.1% at 9 years, with a thromboembolism rate of 8.8%.
Observational (n=83)
Long-term follow-up of the Delrin-disc model of the Björk-Shiley valve prosthesis demonstrates favorable 9-year survival (78.1%) and significant functional improvement, with acceptable rates of thromboembolism and malfunction.
Answers are grounded in this paper and cite their sources.
Offers historical benchmark for Delrin-disc Björk-Shiley durability; leaves open need for randomized comparisons with modern prostheses.
One hundred two Björk-Shiley valve prostheses with the Delrin-disc occluder were implanted in 83 patients between January, 1971, and July, 1972. Fifty-eight were in the mitral position, 42 in the aortic, and 2 in the tricuspid. Complete follow-up until 1981 was obtained in 93% of the patients (mean follow-up, 66.8 months). Hospital mortality was 18% and late mortality, 19%. Survival according to actuarial methods was 84.8% at 5 years and 78.1% at 9 years after operation. Thromboembolism was detected in 8.8% of patients but caused no deaths. The incidence was 1.2% and 1.5% per year in those patients treated with Coumadin and antiplatelet agents, respectively. Reoperation was necessary in 13% of the patients. Most survivors (72%) are in New York Heart Association Functional Class I, despite a preoperative status of Class III or IV in 57% of the patients. Hospital mortality may be due to poorer understanding of patient management and less refined techniques of myocardial protection. Long-term survival with this prosthesis is similar to that in more recent studies, and rates of thromboembolism and malfunction compare favorably with other prosthetic valves.
No takes yet. Share an insight, caveat, or question.
Montero et al. (1984) conducted an observational in Cardiac valve disease requiring replacement (n=83). Delrin-disc model of the Björk-Shiley valve prosthesis was evaluated on Actuarial survival at 5 years. Cardiac valve replacement with the Delrin-disc Björk-Shiley prosthesis yielded an actuarial survival of 84.8% at 5 years and 78.1% at 9 years, with a thromboembolism rate of 8.8%.
Synapse has enriched 10 related papers. Consider them for comparative context: